PKD1 Signaling and Crosstalk Mechanisms in Intestinal Epithelial Cell Regulation
肠上皮细胞调节中的 PKD1 信号传导和串扰机制
基本信息
- 批准号:8759319
- 负责人:
- 金额:$ 33.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AgonistBiologyCell NucleusCell ProliferationCell Proliferation RegulationCellsCessation of lifeCharacteristicsChemicalsChronicComplexDNA biosynthesisDigestive System DisordersDiseaseEmployee StrikesEpithelialEpithelial Cell ProliferationEpithelial CellsEpitheliumG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGastrointestinal tract structureGrowth FactorIn VitroInflammatoryIntestinal MucosaIntestinesKnowledgeLaboratoriesLinkLipidsMalignant NeoplasmsMediatingMembraneN-terminalNeurotransmittersNuclearNuclear ImportOrganellesOrganoidsOutcomePathogenesisPathway interactionsPeptidesPhosphorylationPlayProcessProtein KinaseProteinsRegulationRoleSignal TransductionSignal Transduction PathwayStem cellsStimulusStratum BasaleSystemTestingTherapeutic InterventionTranscriptional ActivationTransgenic MiceWound Healingbasecell typegastrointestinalhuman diseasein vivoinnovationinterestintestinal cryptintestinal homeostasismigrationmouse modelnovelp21 activated kinaseprotein kinase Dpublic health relevancereceptorrepairedresponseresponse to injurystem
项目摘要
DESCRIPTION (provided by applicant): The sequential proliferation, lineage-specific differentiation, migration and death of the epithelial cells of the intestinal mucosa is a tightly regulated process modulated by a broad range of regulatory peptides, neurotransmitters, bioactive lipids and differentiation signals. Despite its fundamental importance for understanding intestinal homeostasis, wound healing and pathogenesis of human diseases, the signaling mechanisms involved remain incompletely understood. Many gastrointestinal (GI) peptides, neurotransmitters and bioactive lipids initiate their characteristic effects in their target cells through heptahelical G protein-coupled receptors (GPCRs). Protein kinase D (PKD1) is emerging as a key node in GPCR signaling and consequently the understanding of PKD1 regulation and function is of intense interest and potential impact. The studies proposed here will identify new links between GPCR/PKD1 signaling and pivotal pathways that control migration and proliferation of intestinal epithelial cells. The overarching hypothesis to be explored is that PKD1 plays a critical role in the signal transduction pathways leading to intestinal epithelial cell proliferation. Three Specific Aims are proposed: Specific Aim 1: Characterize the role of PKD1 signaling in intestinal epithelial cell proliferation in vivo and in stem cell-derived intestinal organoids. This Aim will focus on PKD1 signaling in vivo, examining its function in homeostatic turnover via stem/progenitor cell proliferation and repair in response to injury of the intestinal mucosa, using genetically modified mouse models, including PKD1 transgenic mice and stem-cell derived intestinal organoids. Specific Aim 2) Characterize crosstalk mechanisms between PKD1 and ¿-catenin signaling systems in intestinal epithelial cells. The studies proposed in this Aim will characterize an novel crosstalk between GPCR/PKD1 and ¿-catenin signaling, leading to PKD1/¿- catenin complex formation, ¿-catenin translocation to the nucleus, stimulatory phosphorylation at Ser552 and transcriptional activation; Specific Aim 3) Identify a novel mechanism of PKD1 regulation through PAK-mediated PKD1 phosphorylation at the N-terminal residue Ser203. Based on new preliminary results, we will identify a novel phosphorylation in the N-terminal domain of PKD1 in response to GPCR agonists in intestinal epithelial cells mediated by p21-activated kinases (PAKs), effectors for Rac and Cdc42. The discovery of a PAK/PKD1 cascade uncovers a new point of integration in the signal transduction pathways initiated by GPCR agonists. We anticipate that the mechanistic studies proposed in this application will identify novel upstream pathway(s) and downstream crosstalk mechanisms by which PKD1 regulates the proliferation and migration of intestinal epithelial cells thereby providing the rationale for innovative therapeutic intervention in diseases of the digestive system.
描述(由申请人提供):肠粘膜上皮细胞的连续增殖、谱系特异性分化、迁移和死亡是一个受到广泛调节肽、神经递质、生物活性脂质和分化信号调节的严格调节过程。尽管其对于了解肠道稳态、伤口愈合和人类疾病的发病机制具有重要意义,但许多胃肠道 (GI) 肽、神经递质和相关信号传导机制仍不完全清楚。生物活性脂质通过七螺旋 G 蛋白偶联受体 (GPCR) 在靶细胞中启动其特有作用,蛋白激酶 D (PKD1) 正在成为 GPCR 信号转导的关键节点,因此对 PKD1 调控和功能的理解引起了人们的极大兴趣。本文提出的研究将确定 GPCR/PKD1 信号传导与控制肠上皮细胞迁移和增殖的关键途径之间的新联系。要探索的首要假设是 PKD1 发挥着重要作用。提出了三个具体目标: 具体目标 1:表征 PKD1 信号传导在体内肠上皮细胞增殖和干细胞衍生的肠类器官中的作用。使用转基因小鼠模型(包括 PKD1)研究体内 PKD1 信号传导,通过干/祖细胞增殖和修复响应肠粘膜损伤,检查其在稳态更新中的功能转基因小鼠和干细胞衍生的肠道类器官具体目标 2) 描述 PKD1 和 ¿ 之间的串扰机制。 -肠上皮细胞中的连环蛋白信号系统。本目标中提出的研究将表征 GPCR/PKD1 和 ¿ 之间的新型串扰。 -连环蛋白信号传导,导致 PKD1/¿ - 连环蛋白复合物的形成,¿ -连环蛋白易位至细胞核、Ser552 处的刺激性磷酸化和转录激活;具体目标 3) 通过 PAK 介导的 N 端残基 Ser203 磷酸化确定 PKD1 调节的新机制。肠上皮细胞中 PKD1 N 端结构域响应 GPCR 激动剂的新型磷酸化p21 激活激酶 (PAK)、Rac 和 Cdc42 的效应子 PAK/PKD1 级联的发现揭示了 GPCR 激动剂启动的信号转导途径中的新整合点,我们预计本申请中提出的机制研究将确定这一点。 PKD1 调节肠上皮细胞增殖和迁移的新颖上游途径和下游串扰机制,从而为肠道疾病的创新治疗干预提供了理论基础。消化系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JUAN ENRIQUE ROZENGURT其他文献
JUAN ENRIQUE ROZENGURT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JUAN ENRIQUE ROZENGURT', 18)}}的其他基金
Project 2: Chemoprevention of pancreatic cancer with lipid-lowering and antidiabetic agents
项目2:降脂和抗糖尿病药物化学预防胰腺癌
- 批准号:
10398846 - 财政年份:2020
- 资助金额:
$ 33.5万 - 项目类别:
Project 2: Chemoprevention of pancreatic cancer with lipid-lowering and antidiabetic agents
项目2:降脂和抗糖尿病药物化学预防胰腺癌
- 批准号:
10605232 - 财政年份:2020
- 资助金额:
$ 33.5万 - 项目类别:
Identification of the growth-promoting PKD/YAP axis as a novel target for the statins in intestinal epithelial cells.
鉴定促生长 PKD/YAP 轴作为肠上皮细胞中他汀类药物的新靶点。
- 批准号:
10266021 - 财政年份:2018
- 资助金额:
$ 33.5万 - 项目类别:
Identification of the growth-promoting PKD/YAP axis as a novel target for the statins in intestinal epithelial cells.
鉴定促生长 PKD/YAP 轴作为肠上皮细胞中他汀类药物的新靶点。
- 批准号:
9752221 - 财政年份:2018
- 资助金额:
$ 33.5万 - 项目类别:
PKD1 Signaling and Crosstalk Mechanisms in Intestinal Epithelial Cell Regulation
肠上皮细胞调节中的 PKD1 信号传导和串扰机制
- 批准号:
9126548 - 财政年份:2014
- 资助金额:
$ 33.5万 - 项目类别:
PKD1 Signaling and Crosstalk Mechanisms in Intestinal Epithelial Cell Regulation
肠上皮细胞调节中的 PKD1 信号传导和串扰机制
- 批准号:
8915687 - 财政年份:2014
- 资助金额:
$ 33.5万 - 项目类别:
Chemoprevention of pancreatic cancer witli antidiabetic agents
使用抗糖尿病药物化学预防胰腺癌
- 批准号:
8561428 - 财政年份:2013
- 资助金额:
$ 33.5万 - 项目类别:
Calcium-sensing receptor signaling in the regulation of colonic epithelial cells
钙敏感受体信号传导在结肠上皮细胞的调节中
- 批准号:
8510389 - 财政年份:2012
- 资助金额:
$ 33.5万 - 项目类别:
Calcium-sensing receptor signaling in the regulation of colonic epithelial cells
钙敏感受体信号传导在结肠上皮细胞的调节中
- 批准号:
8970680 - 财政年份:2012
- 资助金额:
$ 33.5万 - 项目类别:
Chemoprevention of pancreatic cancer witli antidiabetic agents
使用抗糖尿病药物化学预防胰腺癌
- 批准号:
8373906 - 财政年份:2012
- 资助金额:
$ 33.5万 - 项目类别:
相似国自然基金
化学生物学方法探索细胞核与核仁蛋白焦磷酸化的分子机制研究
- 批准号:22161132006
- 批准年份:2021
- 资助金额:300 万元
- 项目类别:
三维力学微环境调控肿瘤细胞核形变与基因簇重构的力学生物学机制
- 批准号:12132004
- 批准年份:2021
- 资助金额:320 万元
- 项目类别:重点项目
肿瘤细胞运动与迁移中细胞核形变与修复的力学生物学调控机制
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
细胞核在血管重建中的力学生物学响应机制
- 批准号:
- 批准年份:2020
- 资助金额:310 万元
- 项目类别:重点项目
细胞核骨架蛋白调控microRNA功能簇在移植静脉新生内膜增生中的作用及其力学生物学机制
- 批准号:11972232
- 批准年份:2019
- 资助金额:64 万元
- 项目类别:面上项目
相似海外基金
Mechanisms of estrogen receptor ligand signaling
雌激素受体配体信号传导机制
- 批准号:
10681785 - 财政年份:2023
- 资助金额:
$ 33.5万 - 项目类别:
Compartmentalized signaling and crosstalk in airway myocytes
气道肌细胞中的区室化信号传导和串扰
- 批准号:
10718208 - 财政年份:2023
- 资助金额:
$ 33.5万 - 项目类别:
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy
ZBP1 驱动的核坏死性凋亡的小分子开发用于癌症免疫治疗
- 批准号:
10586659 - 财政年份:2023
- 资助金额:
$ 33.5万 - 项目类别:
Fibrosis, inflammation, and osteophyte formation in post-traumatic osteoarthritis
创伤后骨关节炎中的纤维化、炎症和骨赘形成
- 批准号:
10570315 - 财政年份:2023
- 资助金额:
$ 33.5万 - 项目类别: